MMP11 and breast cancer: The knockdown of circ-MMP11 significantly increased lapatinib sensitivity by reducing cell viability, migration, and invasion, implying targeting circ-MMP11/ miR-153-3p/ANLN axis in lapatinib resistance of BC (Table 2).